comparemela.com
Home
Live Updates
Jacobio Pharma Presents Data of Glecirasib in Patients with Pancreatic Cancer and Other Solid Tumors at the 2024 ASCO GI : comparemela.com
Jacobio Pharma Presents Data of Glecirasib in Patients with Pancreatic Cancer and Other Solid Tumors at the 2024 ASCO GI
BEIJING and SAN FRANCISCO, Jan. 20, 2024 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK), a clinical-stage oncology company focusing on undruggable targets,
Related Keywords
Lin Shen
,
Guangdong
,
China
,
Israel
,
Beijing
,
United States
,
Peking
,
American
,
,
American Society Of Clinical Oncology
,
University Cancer Hospital
,
National Medical Products Administration
,
Jacobio Pharmaceuticals
,
American Society
,
Clinical Oncology
,
Gastrointestinal Cancers Symposium
,
Peking University Cancer Hospital
,
New Drug Application
,
Drug Evaluation
,
comparemela.com © 2020. All Rights Reserved.